We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Goldman Sachs Group, PepsiCo, Johnson & Johnson, Cummins and Fidelity National Information Services
Read MoreHide Full Article
For Immediate Release
Chicago, IL – September 28, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Goldman Sachs Group Inc. (NYSE:(GS - Free Report) – Free Report), PepsiCo, Inc. (NYSE:(PEP - Free Report) – Free Report), Johnson & Johnson (NYSE:(JNJ - Free Report) – Free Report), Cummins Inc. (NYSE:(CMI - Free Report) – Free Report) and Fidelity National Information Services Inc. (NYSE:(FIS - Free Report) – Free Report).
Here are highlights from Wednesday’s Analyst Blog:
Top Stock Reports for Goldman Sachs, Pepsico and Johnson & Johnson
The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 12 major stocks, including Goldman Sachs Group Inc. (NYSE:(GS - Free Report) – Free Report), PepsiCo, Inc. (NYSE:(PEP - Free Report) – Free Report) and Johnson & Johnson (NYSE:(JNJ - Free Report) – Free Report). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Goldman Sachs’ shares have lost -3.9% in the year-to-date period, compared with the +11.3% gain of the Zacks Investment Bank industry. Yet the company carries an impressive earnings surprise history. It has surpassed the Zacks Consensus Estimate for earnings in three of the trailing four quarters.
Though the company’s well-diversified business, expected lesser regulations and its focus to capitalize on growth opportunities through strategic moves should continue to bolster overall business, various lawsuits which have yet to be resolved are likely to lead to elevated expenses and litigation provisions in the near term.
PepsiCo’s shares have gained +4.1% over the last year, outperforming the Zacks Soft Beverages industry, which has increased +3.8% over the same period. PepsiCo has been doing well on the back of significant innovation, continued momentum in Frito-Lay business, revenue management strategies, improved productivity and cost-saving initiatives, along with better market execution.
Moreover, it has been seeing higher volumes and profits in the North American segments due to an improving economy, better industry pricing dynamics and a consistency in positive innovation.
Johnson & Johnson’s shares have gained +13.8% in the year-to-date period, compared with the +11.8% gain of the Zacks Large Cap Pharmaceuticals industry. J&J is optimistic that sales growth will accelerate in 2H17. We believe that new drugs like Xarelto, Stelara, Darzalex and Imbruvica remain the key to growth.
Meanwhile, share buybacks and restructuring initiatives should provide bottom-line support. J&J is also making rapid progress with its pipeline and line extensions. The Actelion buy adds an attractive new therapeutic area – PAH – which should contribute to sales growth.
With news stories about computer hacking and identity theft becoming increasingly commonplace, the cybersecurity industry looks like a promising investment opportunity. But which stocks should you buy? Zacks just released Cybersecurity: An Investor’s Guide to Locking Down Profits to help answer this question.
This new Special Report gives you the information you need to make well-informed investment choices in this space. More importantly, it also highlights 4 cybersecurity picks with strong profit potential.
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year.See these high-potential stocks free >>.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Goldman Sachs Group, PepsiCo, Johnson & Johnson, Cummins and Fidelity National Information Services
For Immediate Release
Chicago, IL – September 28, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Goldman Sachs Group Inc. (NYSE:(GS - Free Report) – Free Report), PepsiCo, Inc. (NYSE:(PEP - Free Report) – Free Report), Johnson & Johnson (NYSE:(JNJ - Free Report) – Free Report), Cummins Inc. (NYSE:(CMI - Free Report) – Free Report) and Fidelity National Information Services Inc. (NYSE:(FIS - Free Report) – Free Report).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Wednesday’s Analyst Blog:
Top Stock Reports for Goldman Sachs, Pepsico and Johnson & Johnson
The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 12 major stocks, including Goldman Sachs Group Inc. (NYSE:(GS - Free Report) – Free Report), PepsiCo, Inc. (NYSE:(PEP - Free Report) – Free Report) and Johnson & Johnson (NYSE:(JNJ - Free Report) – Free Report). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Goldman Sachs’ shares have lost -3.9% in the year-to-date period, compared with the +11.3% gain of the Zacks Investment Bank industry. Yet the company carries an impressive earnings surprise history. It has surpassed the Zacks Consensus Estimate for earnings in three of the trailing four quarters.
Though the company’s well-diversified business, expected lesser regulations and its focus to capitalize on growth opportunities through strategic moves should continue to bolster overall business, various lawsuits which have yet to be resolved are likely to lead to elevated expenses and litigation provisions in the near term.
(You can read the full research report on Goldman Sachs here >>>).
PepsiCo’s shares have gained +4.1% over the last year, outperforming the Zacks Soft Beverages industry, which has increased +3.8% over the same period. PepsiCo has been doing well on the back of significant innovation, continued momentum in Frito-Lay business, revenue management strategies, improved productivity and cost-saving initiatives, along with better market execution.
Moreover, it has been seeing higher volumes and profits in the North American segments due to an improving economy, better industry pricing dynamics and a consistency in positive innovation.
(You can read the full research report on PepsiCo here >>>).
Johnson & Johnson’s shares have gained +13.8% in the year-to-date period, compared with the +11.8% gain of the Zacks Large Cap Pharmaceuticals industry. J&J is optimistic that sales growth will accelerate in 2H17. We believe that new drugs like Xarelto, Stelara, Darzalex and Imbruvica remain the key to growth.
Meanwhile, share buybacks and restructuring initiatives should provide bottom-line support. J&J is also making rapid progress with its pipeline and line extensions. The Actelion buy adds an attractive new therapeutic area – PAH – which should contribute to sales growth.
(You can read the full research report on Johnson & Johnson here >>>).
Other noteworthy reports we are featuring today include Cummins Inc. (NYSE:(CMI - Free Report) – Free Report) and Fidelity National Information Services Inc. (NYSE:(FIS - Free Report) – Free Report).
4 Promising Stock Picks to Keep an Eye On
With news stories about computer hacking and identity theft becoming increasingly commonplace, the cybersecurity industry looks like a promising investment opportunity. But which stocks should you buy? Zacks just released Cybersecurity: An Investor’s Guide to Locking Down Profits to help answer this question.
This new Special Report gives you the information you need to make well-informed investment choices in this space. More importantly, it also highlights 4 cybersecurity picks with strong profit potential.
Get the new Investing Guide now>>
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year.See these high-potential stocks free >>.
Get the full Report on GS - FREE
Get the full Report on PEP - FREE
Get the full Report on JNJ - FREE
Get the full Report on CMI - FREE
Get the full Report on FIS - FREE
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.